Syntax Bio's regenerative medicine discovery platform overcomes the longstanding challenges in stem cell derived therapies by directly controlling and accelerating cell differentiation. A shorter and more reliable iPSC differentiation process improves patient access by making stem cell discovery and manufacturing faster, less costly and scalable. Synatx’s proprietary Cellgorithm technology mimics human development using a sequential synthetic biology CRISPR based system to generate a wide diversity of functional cell types to enable new cell and gene therapy product opportunities.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Chicago, Il, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.syntax-bio.com/
- HQ
- Chicago, IL
Syntax Bio Questions
Syntax Bio's website is https://www.syntax-bio.com/
Syntax Bio's LinkedIn profile is https://www.linkedin.com/company/syntax-bio
Syntax Bio has
13 employees.
View email and phone details for 13
employees at Syntax Bio.
Syntax Bio's industry is
Biotechnology Research
Syntax Bio's top competitors are
Arzeda,
Nura Bio,
Neo Medical,
Nomic Bio,
Gc Therapeutics,
Pictorlabs Inc,
Ascendis Pharma,
Nuvalent, Inc.,
Hippocratic Ai,
Cellco - The Cell Company.
Syntax Bio's categories are Biotechnology Research
Syntax Bio's founding year is 2021
